Added to YB: 2021-04-01
Pitch date: 2021-04-01
ANAB:US [bullish]
AnaptysBio, Inc.
+182.74%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.
Market Cap
$1.6B
Pitch Price
$22.08
Price Target
N/A
Dividend
N/A
EV/EBITDA
30.85
P/E
-120.38
EV/Sales
6.70
Sector
Biotechnology
Category
N/A
Show full summary:
AnaptysBio, Inc. ANAB:US
A summary for this pitch has not been created yet.
Read full article (0 min)